Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Brain & Spine
|
December 12, 2022
Working in low- and middle-income countries: Learning from each other
Jake Timothy, Marcel Ivanov, Magnus Tisell, et al.
BMJ Open
|
December 9, 2023
Specialist healthcare services for concussion/mild traumatic brain injury in England: a consensus statement using modified Delphi methodology
Elika Karvandi, Adel Helmy, Angelos G Kolias, et al.
Trials
|
December 6, 2018
Dexamethasone for adult patients with a symptomatic chronic subdural haematoma (Dex-CSDH) trial: study protocol for a randomised controlled trial
Angelos G Kolias, Ellie Edlmann, Eric P Thelin, et al.
Trials
|
March 20, 2019
Correction to: Dexamethasone for adult patients with a symptomatic chronic subdural haematoma (Dex-CSDH) trial: study protocol for a randomised controlled trial
Angelos G Kolias, Ellie Edlmann, Eric P Thelin, et al.
BMJ Open
|
March 17, 2023
Risk of Aneurysm Rupture (ROAR) study: protocol for a long-term, longitudinal, UK multicentre study of unruptured intracranial aneurysms
Samuel Hall, Jacqueline Birks, Ian Anderson, et al.
British Journal of Neurosurgery
|
November 5, 2021
A survey of the radiological follow-up of unruptured intracranial aneurysms in the United Kingdom
Samuel Hall, Ashraf Abouharb, Ian Anderson, et al.
Scientific Reports
|
April 12, 2019
Dex-CSDH randomised, placebo-controlled trial of dexamethasone for chronic subdural haematoma: report of the internal pilot phase
Ellie Edlmann, Eric P Thelin, Karen Caldwell, et al.
Health Technology Assessment (Winchester, England)
|
March 21, 2024
A randomised, double blind, placebo-controlled trial of a two-week course of dexamethasone for adult patients with a symptomatic Chronic Subdural Haematoma (Dex-CSDH trial)
Peter J Hutchinson, Ellie Edlmann, John G Hanrahan, et al.
Nature Communications
|
May 7, 2025
Genomic landscape of diffuse glioma revealed by whole genome sequencing
Ben Kinnersley, Josephine Jung, Alex J Cornish, et al.
Wellcome Open Research
|
March 4, 2024
Protocol for the development of a multidisciplinary clinical practice guideline for the care of patients with chronic subdural haematoma
Daniel J Stubbs, Benjamin M Davies, Mary Dixon-Woods, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Brain & Spine
|
December 12, 2022
Working in low- and middle-income countries: Learning from each other
Jake Timothy, Marcel Ivanov, Magnus Tisell, et al.
BMJ Open
|
December 9, 2023
Specialist healthcare services for concussion/mild traumatic brain injury in England: a consensus statement using modified Delphi methodology
Elika Karvandi, Adel Helmy, Angelos G Kolias, et al.
Trials
|
December 6, 2018
Dexamethasone for adult patients with a symptomatic chronic subdural haematoma (Dex-CSDH) trial: study protocol for a randomised controlled trial
Angelos G Kolias, Ellie Edlmann, Eric P Thelin, et al.
Trials
|
March 20, 2019
Correction to: Dexamethasone for adult patients with a symptomatic chronic subdural haematoma (Dex-CSDH) trial: study protocol for a randomised controlled trial
Angelos G Kolias, Ellie Edlmann, Eric P Thelin, et al.
BMJ Open
|
March 17, 2023
Risk of Aneurysm Rupture (ROAR) study: protocol for a long-term, longitudinal, UK multicentre study of unruptured intracranial aneurysms
Samuel Hall, Jacqueline Birks, Ian Anderson, et al.
British Journal of Neurosurgery
|
November 5, 2021
A survey of the radiological follow-up of unruptured intracranial aneurysms in the United Kingdom
Samuel Hall, Ashraf Abouharb, Ian Anderson, et al.
Scientific Reports
|
April 12, 2019
Dex-CSDH randomised, placebo-controlled trial of dexamethasone for chronic subdural haematoma: report of the internal pilot phase
Ellie Edlmann, Eric P Thelin, Karen Caldwell, et al.
Health Technology Assessment (Winchester, England)
|
March 21, 2024
A randomised, double blind, placebo-controlled trial of a two-week course of dexamethasone for adult patients with a symptomatic Chronic Subdural Haematoma (Dex-CSDH trial)
Peter J Hutchinson, Ellie Edlmann, John G Hanrahan, et al.
Nature Communications
|
May 7, 2025
Genomic landscape of diffuse glioma revealed by whole genome sequencing
Ben Kinnersley, Josephine Jung, Alex J Cornish, et al.
Wellcome Open Research
|
March 4, 2024
Protocol for the development of a multidisciplinary clinical practice guideline for the care of patients with chronic subdural haematoma
Daniel J Stubbs, Benjamin M Davies, Mary Dixon-Woods, et al.
Page
of 2